Tandem Diabetes Care (TNDM) PT Raised to $57 at Oppenheimer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Tandem Diabetes Care (TNDM) PT Raised to $57 at Oppenheimer

Tandem Diabetes Care Increases 2018 Sales Guidance and Provides Estimated Third Quarter Sales Results

September 25, 2018 9:00 AM EDT

Continued Domestic Demand and International Launch of the t:slim X2 Insulin Pump Drive Growth

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced that it has increased its 2018 sales guidance to $150 million to $158 million, from $140 million to $148 million, following continued strong domestic sales in the third quarter and the recent launch of the t:slim X2 Insulin Pump in select international markets. Compared to 2017 sales of approximately $108 million,... More